アジア太平洋地域の不妊症 検査と治療市場予測　2021-2028年

ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET FORECAST 2021-2028

このレポートへお問合せ

レポート目次

Report Details

この調査レポートはアジア太平洋地域の不妊症 検査と治療市場を分析・予測したInkwood Researchの市場調査報告書です。

Overview

KEY FINDINGS
The Asia-Pacific infertility testing & treatment market is projected to develop with a CAGR of 10.90% over the forecasting years. The market growth of the region is essentially driven by factors such as the accessibility to affordable treatments, the accelerated adoption of fertility procedures, and the rise in fertility tourism.
MARKET INSIGHTS
The Asia-Pacific infertility testing & treatment market growth evaluation entails the assessment of South Korea, India, Vietnam, China, Japan, Indonesia, Australia & New Zealand, Thailand, and the rest of the Asia-Pacific. India is anticipated to depict the fastest growth across the region during the estimated period. Rising stress levels, sedentary lifestyles with minimal physical activity, and irregular sleep patterns are widely prevalent in India. As a result, approximately 27.5 million couples actively trying to conceive in the country suffer from infertility, according to several health experts and clinicians. This aspect compels couples to opt for artificial approaches to conception. Moreover, as per the Indian Society of Assisted Reproduction, infertility presently impacts up to 14% of the Indian population, with increased rates observed in urban areas.
In South Korea, infertility treatment, especially IVF, has one of the highest price-quality success ratios across all developed nations globally. Currently, the country has more than 150 clinics as registered IVF centers. In addition to research institutions, these facilities continually aim to improvise the outcome of IVF and their respective success rates by predominantly concentrating on culture conditions for oocyte IVM. Therefore, these factors are anticipated to facilitate the Asia-Pacific infertility testing & treatment market growth during the forecast period.
COMPETITIVE INSIGHTS
Some of the key firms operating in the market are Genea Ltd, Olympus Corporation, Bangkok IVF Center, etc.
Our report offerings include:
– Explore key findings of the overall market
– Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
– Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
– Market Segmentation cater to a thorough assessment of key segments with their market estimations
– Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
– Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
– Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
– Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

目次

Table of Contents

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. GROWING STRESS AND LIFESTYLE DISORDERS
3.1.2. INCREASED AGE OF CONCEPTION
3.1.3. INCREASING EFFECTIVENESS OF TREATMENTS
3.1.4. RISING GOVERNMENT SUPPORT
3.2. KEY RESTRAINTS
3.2.1. HIGH COST OF TESTING AND TREATMENT
3.2.2. INFERTILITY CONSIDERED A SOCIAL TABOO
3.2.3. POSSIBLE RISKS ASSOCIATED WITH INFERTILITY TREATMENTS
4. KEY ANALYTICS
4.1. IMPACT OF COVID-19 ON INFERTILITY TESTING & TREATMENT MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER’S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. OPPORTUNITY MATRIX
4.5. VENDOR LANDSCAPE
4.6. KEY BUYING CRITERIA
4.6.1. TREATMENT OPTIONS
4.6.2. QUALITY OF MEDICAL PROCEDURES
4.6.3. PRICE OF TREATMENTS
4.6.4. SHIFT TOWARDS MEDICAL TOURISM
4.6.5. REIMBURSEMENT
4.7. VALUE CHAIN ANALYSIS
4.7.1. RAW MATERIAL PROCUREMENT
4.7.2. MANUFACTURING
4.7.3. SUPPLY LOGISTICS
4.7.4. DISTRIBUTION CHANNELS
4.7.5. END-USERS
5. MARKET BY GENDER
5.1. MALE
5.1.1. MALE INFERTILITY TESTING
5.1.1.1. DNA FRAGMENTATION
5.1.1.2. OXIDATIVE STRESS ANALYSIS
5.1.1.3. SPERM PENETRATION ASSAY
5.1.1.4. COMPUTER-ASSISTED SEMEN ANALYSIS (CASA)
5.1.1.5. SPERM AGGLUTINATION
5.1.1.6. MICROSCOPIC EXAMINATION
5.1.1.7. OTHERS
5.1.2. MALE INFERTILITY TREATMENT
5.1.2.1. MEDICATION
5.1.2.2. ASSISTED REPRODUCTIVE TECHNOLOGY & VARICOCELE SURGERY
5.2. FEMALE
5.2.1. FEMALE INFERTILITY TESTING
5.2.1.1. OVULATION TESTING
5.2.1.2. HYSTEROSALPINGOGRAPHY
5.2.1.3. LAPAROSCOPY
5.2.1.4. TRANSVAGINAL ULTRASOUND
5.2.1.5. OVARIAN RESERVE TESTING
5.2.1.6. HORMONAL LEVEL TESTING
5.2.1.7. OTHERS
5.2.2. FEMALE INFERTILITY TREATMENT
5.2.2.1. IVF WITH ICSI
5.2.2.2. IUI
5.2.2.3. IVF WITHOUT ICSI
5.2.2.4. SURROGACY
5.2.2.5. OTHERS
6. MARKET BY END-USER
6.1. FERTILITY AND SURGICAL CENTERS
6.2. HOSPITALS AND RESEARCH LABORATORIES
6.3. CRYOBANKS
7. GEOGRAPHICAL ANALYSIS
7.1. ASIA-PACIFIC
7.1.1. KEY GROWTH ENABLERS
7.1.2. KEY CHALLENGES
7.1.3. KEY PLAYERS
7.1.4. COUNTRY ANALYSIS
7.1.4.1. CHINA
7.1.4.2. JAPAN
7.1.4.3. INDIA
7.1.4.4. SOUTH KOREA
7.1.4.5. INDONESIA
7.1.4.6. THAILAND
7.1.4.7. VIETNAM
7.1.4.8. AUSTRALIA & NEW ZEALAND
7.1.4.9. REST OF ASIA-PACIFIC
8. COMPETITIVE LANDSCAPE
8.1. KEY STRATEGIC DEVELOPMENTS
8.1.1. MERGERS & ACQUISITIONS
8.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
8.1.3. PARTNERSHIP & AGREEMENTS
8.2. COMPANY PROFILES
8.2.1. ADORFEM
8.2.2. BANGKOK IVF CENTER
8.2.3. COOK MEDICAL INC
8.2.4. COOPER SURGICAL
8.2.5. CREATE FERTILITY CENTRE
8.2.6. EMD GROUP (MERCK KGAA)
8.2.7. ENDO INTERNATIONAL PLC
8.2.8. ESCO MEDICAL
8.2.9. FERRING PHARMACEUTICALS
8.2.10. FERTILITY FIRST
8.2.11. FUJIFILM IRVINE SCIENTIFIC
8.2.12. GENEA LTD
8.2.13. HALOTECH DNA
8.2.14. HAMILTON THRONE LTD
8.2.15. IVFTECH
8.2.16. LABOTECT GMBH
8.2.17. OLYMPUS CORPORATION
8.2.18. PROGYNY
8.2.19. THERMO FISHER SCIENTIFIC INC
8.2.20. VITROLIFE AB

List of Tables

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – INFERTILITY TESTING & TREATMENT
TABLE 2: AVERAGE COST COMPARISON OF INFERTILITY TREATMENTS
TABLE 3: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY GENDER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 4: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY GENDER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 5: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY MALE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 6: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY MALE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 7: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TESTING, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 8: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TESTING, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 9: PROS AND CONS OF DNA SHARING METHODS
TABLE 10: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 11: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 12: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 13: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 14: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 15: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 16: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 17: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 18: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 19: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 20: LIST OF MERGERS & ACQUISITIONS
TABLE 21: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 22: LIST OF PARTNERSHIPS & AGREEMENTS

List of Figures

LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: KEY BUYING CRITERIA
FIGURE 6: VALUE CHAIN ANALYSIS
FIGURE 7: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY GENDER, IN 2020
FIGURE 8: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY MALE, 2021-2028 (IN $ MILLION)
FIGURE 9: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY MALE, IN 2020
FIGURE 10: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TESTING, 2021-2028 (IN $ MILLION)
FIGURE 11: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY MALE INFERTILITY TESTING, IN 2020
FIGURE 12: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY DNA FRAGMENTATION, 2021-2028 (IN $ MILLION)
FIGURE 13: CAUSES OF SPERM DNA FRAGMENTATION
FIGURE 14: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY OXIDATIVE STRESS ANALYSIS, 2021-2028 (IN $ MILLION)
FIGURE 15: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY SPERM PENETRATION ASSAY, 2021-2028 (IN $ MILLION)
FIGURE 16: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY COMPUTER-ASSISTED SEMEN ANALYSIS (CASA), 2021-2028 (IN $ MILLION)
FIGURE 17: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY SPERM AGGLUTINATION, 2021-2028 (IN $ MILLION)
FIGURE 18: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY MICROSCOPIC EXAMINATION, 2021-2028 (IN $ MILLION)
FIGURE 19: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY OTHERS, 2021-2028 (IN $ MILLION)
FIGURE 20: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, 2021-2028 (IN $ MILLION)
FIGURE 21: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY MALE INFERTILITY TESTING, IN 2020
FIGURE 22: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY MEDICATION, 2021-2028 (IN $ MILLION)
FIGURE 23: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY ASSISTED REPRODUCTIVE TECHNOLOGY & VARICOCELE SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 24: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE, 2021-2028 (IN $ MILLION)
FIGURE 25: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY FEMALE, IN 2020
FIGURE 26: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, 2021-2028 (IN $ MILLION)
FIGURE 27: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY FEMALE INFERTILITY TESTING, IN 2020
FIGURE 28: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY OVULATION TESTING, 2021-2028 (IN $ MILLION)
FIGURE 29: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY HYSTEROSALPINGOGRAPHY, 2021-2028 (IN $ MILLION)
FIGURE 30: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY LAPAROSCOPY, 2021-2028 (IN $ MILLION)
FIGURE 31: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY TRANSVAGINAL ULTRASOUND, 2021-2028 (IN $ MILLION)
FIGURE 32: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY OVARIAN RESERVE TESTING, 2021-2028 (IN $ MILLION)
FIGURE 33: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY HORMONAL LEVEL TESTING, 2021-2028 (IN $ MILLION)
FIGURE 34: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY OTHERS, 2021-2028 (IN $ MILLION)
FIGURE 35: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, 2021-2028 (IN $ MILLION)
FIGURE 36: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY FEMALE INFERTILITY TREATMENT, IN 2020
FIGURE 37: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY IVF WITH ICSI, 2021-2028 (IN $ MILLION)
FIGURE 38: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY IUI, 2021-2028 (IN $ MILLION)
FIGURE 39: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY IVF WITHOUT ICSI, 2021-2028 (IN $ MILLION)
FIGURE 40: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY SURROGACY, 2021-2028 (IN $ MILLION)
FIGURE 41: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY OTHERS, 2021-2028 (IN $ MILLION)
FIGURE 42: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY END-USER, IN 2020
FIGURE 43: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY FERTILITY AND SURGICAL CENTERS, 2021-2028 (IN $ MILLION)
FIGURE 44: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY HOSPITALS AND RESEARCH LABORATORIES, 2021-2028 (IN $ MILLION)
FIGURE 45: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY CRYOBANKS, 2021-2028 (IN $ MILLION)
FIGURE 46: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE 47: CHINA INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 48: JAPAN INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 49: INDIA INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 50: SOUTH KOREA INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 51: INDONESIA INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 52: THAILAND INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 53: VIETNAM INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 54: AUSTRALIA & NEW ZEALAND INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 55: REST OF ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)

お問合せフォーム

プライバシーポリシーはこちらをご覧ください。